Emilande Guichet

African origin of the malaria parasite Plasmodium vivax

Weimin Liu, Yingying Li, Katharina S. Shaw et al. · Nature Communications · 2014 · 232 citations · Full text

Malaria, Vector-parasite Relationship, Medicine +2

Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial

Laura Ciaffi, Sinata Koulla‐Shiro, Adrien Sawadogo et al. · The Lancet HIV · 2017 · 71 citations

Lamivudine Dual Therapy, Superiority Trial, Protease Inhibitor +9

High Prevalence of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (Anti–SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey

Antoine Nkuba-Ndaye, Sheila Makiala‐Mandanda, Emilande Guichet et al. · Clinical Infectious Diseases · 2021 · 50 citations · Full text

Deciphering Morphological Determinants of the Helix-Shaped Leptospira

Leyla Slamti, Miguel A. de Pedro, Emilande Guichet et al. · Journal of Bacteriology · 2011 · 44 citations · Full text

Short Communication: High Viral Load and Multidrug Resistance Due to Late Switch to Second-Line Regimens Could Be a Major Obstacle to Reach the 90-90-90 UNAIDS Objectives in Sub-Saharan Africa

Emilande Guichet, Avelin F. Aghokeng, Laetitia Serrano et al. · AIDS Research and Human Retroviruses · 2016 · 30 citations